Skip to main content

Adaptive Biotechnologies beats expectations in Q3

The company said in its earnings announcement that it has now identified two antibodies against the Covid-19 that neutralize it at very low concentrations.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.